RECIST (Response Evaluation Criteria In Solid Tumors) is a set of standardized guidelines used to assess and quantify the response of solid tumors to treatment in clinical trials. Introduced in 2000 and revised as RECIST 1.1 in 2009, these criteria provide a consistent method to measure tumor size and response, which is critical for evaluating the efficacy of oncological therapies.
